Asia-Pacific Joint Resurfacing Devices Market Size and Forecast (2021 - 2031)

The Asia Pacific Joint Resurfacing Devices Market is projected to grow significantly, reaching an estimated US$ 635.5 million by 2031, up from US$ 445.3 million in 2024, reflecting a compound annual growth rate (CAGR) of 5.3% from 2025 to 2031. This growth is driven by several factors, including increased healthcare access, government investments in infrastructure, and a rapidly aging population. According to the United Nations, the population aged over 65 in Asia is expected to reach nearly 1.3 billion by 2050, which will further escalate the demand for joint resurfacing procedures.

The market is segmented into key countries: China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Notably, India is projected to see a 15% annual increase in knee-related disorders, as indicated by national health surveys. In July 2025, Care Hospitals in Hyderabad introduced the AI-powered Stryker Mako Robotic System for joint resurfacing surgeries, which utilizes 3D CT-based planning to achieve 98% accuracy in joint alignment and has reportedly reduced recovery times by 30%.

Urban lifestyles in China and Japan are contributing to increased joint wear, leading to a higher adoption of resurfacing procedures. The Indian government allocated US$ 11.5 billion (Rs. 99,858 crore) to healthcare in the 2025-2026 Union Budget, which is expected to support the growth of surgical infrastructure. Japan's Ministry of Health anticipates over 200,000 hip resurfacing procedures annually by 2025, supported by innovations like Zimmer Biomet's 3D-printed personalized implants, which offer a 92% ten-year survivorship rate for active patients.

Australia and South Korea are focusing on minimally invasive techniques, with South Korea's national insurance covering 80% of resurfacing costs for shoulder reconstructions due to occupational injuries. Initiatives such as Australia's Medicare expansions and ASEAN health pacts in Southeast Asia are bridging healthcare gaps, resulting in an 18% increase in procedure volumes in 2024. Technological advancements, including OXINIUM coatings from Smith and Nephew, which have shown 35% fewer revisions in clinical trials, are gaining traction in the market.

The Asia Pacific region is also a hub for medical tourism, with Thailand performing approximately 50,000 resurfacing surgeries annually. Collaborative research and development through organizations like the Asia Pacific Orthopaedic Association is positioning the region as a leader in cost-effective, high-precision joint preservation solutions, which are crucial for restoring mobility to millions.

In terms of market segmentation, the Asia Pacific Joint Resurfacing Devices Market is categorized by type (Knee, Hip, Shoulder, Ankle, and Others), material (Metal, Ceramic, and Others), and end user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others). The Knee segment was the market leader in 2024, as was the Metal segment in terms of material. Hospitals dominated the end-user segment in the same year.

Technological advancements in minimally invasive surgery (MIS) techniques and implant designs are accelerating the adoption of joint resurfacing devices over traditional open procedures. Innovations such as posterior MIS approaches and uncemented metal-on-metal implants have made resurfacing a viable outpatient option, minimizing tissue trauma and postoperative complications. Patients under 65 with osteoarthritis (OA) have reported a 95% satisfaction rate with MIS, highlighting its advantages over traditional methods. For instance, in knee resurfacing using minimally invasive total knee arthroplasty (MIS-TKA), blood loss was reduced by 22% compared to conventional methods, although hospital stays remained similar.

Broader integrations of technology, such as AI and augmented reality systems like the Tianji robot, have enabled over 30,000 precise resections in China, enhancing accuracy in treating osteoarthritis and avascular necrosis. These advancements not only reduce costs—outpatient hip resurfacing arthroplasty has shown savings of 33-61% compared to inpatient procedures—but also expand access to care. For active patients, innovations in posterior-stabilized mobile-bearing implants in MIS TKA have led to quicker recovery times and improved outcomes.

By country, China holds the largest market share, driven by an aging population and rising osteoarthritis prevalence. The National Health Commission reported that the population over 60 reached 280 million in 2023, intensifying the demand for minimally invasive joint resurfacing options. Notable developments include Medtronic's modular hip reconstruction system, which has been tailored for Asian anatomies and has shown to reduce recovery times significantly.

Key players in the Asia Pacific Joint Resurfacing Devices Market include MicroPort Scientific Corp, Stryker Corp, Zimmer Biomet Holdings Inc, Smith & Nephew Plc, and others. These companies are focusing on expansion, product innovation, and strategic mergers and acquisitions to enhance their market presence.